A. Prilenskaya

Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia

S. Sivertseva, G. Makshakov, M. Shumilina, 2019, PloS one.

[The risk of ischemic stroke in patients with multiple sclerosis].

S. Sivertseva, M. Guseva, A. Boyko, 2018, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.